Introduction: The diagnosis of adrenal hormonally inactive adenoma is made when a precise endocrine examination rules out the presence of hormonal oversecretion. More and more data indicate an association between hormonally inactive adrenal adenomas and some components of cardiometabolic risk—insulin resistance, obesity, hypertension, hyperglycemia and dyslipidemia.
Aim: The main goal of the present study is to determine the frequency of individual nosological units, metabolic syndrome and obesity in patients with adrenal hormonally inactive adenomas and their relationship to anthropometric indicators.
Materials and Methods: The subject of the study were 105 patients with hormonally inactive adrenal adenomas, passed through the Clinic of Endocrinology and Metabolic Diseases at St. Marina University Hospital. The results are processed with SPSS v. 20.0, using variance, variation, correlation and comparative analyses, and risk assessment analysis. We take p < 0.05 as the significance level.
Results: A proportionally weak relationship between gender and waist circumference has been established. There is a significant difference in the relative share of men and women with HDL level above the norm (p < 0.001). In addition, BMI, arterial hypertension, cholesterol, HDL and fasting blood glucose does not correlate with gender. Triglycerides are found to have a weak correlation with gender. A significant difference was found in the relative proportion of men with serum HDL levels < 1.03 mmol/L with a waist circumference below and above 94 cm (p = 0.001), and there is an inversely proportional moderate dependence between waist circumference in men with inactive adrenal glands adenomas and serum HDL levels (r = -0.369; p < 0.001). It is found that men with hormonal inactive adrenal adenomas, having waist circumference > 94 cm have an 8 times higher risk of decreased serum HDL levels (OR = 8.0) (2.43-26.33); p < 0.001). A positive moderate dependence was found between uric acid serum levels with GGT and FLI.
Conclusion: Additional research is needed to conclude whether these patients have an altered metabolic profile and have a statistically increased risk of cardiovascular disease and mortality.
Борисова А-М. Епидемиология на ендокринните заболявания в България, 2006-2012 г, изд. Парадигма, 2016
Abdullah A, Peeters A, de Courten M, Stoelwinder J. The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies. Diabetes Res Clin Pract. 2010 Sep;89(3):309-19. doi: 10.1016/j.diabres.2010.04.012
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009 Oct 20;120(16):1640-5. doi: 10.1161/CIRCULATIONAHA.109.192644
Berthezene, E. Diabetic dyslipideia. Br J Diab Vasc Dis, 2 ,2002, 1, S12- S17
Barzon L, Sonino N, Fallo F, Palu G, Boscaro M. Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol. 2003 Oct;149(4):273-85. doi: 10.1530/eje.0.1490273
Bernini G, Moretti A, Iacconi P et al. Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery. Eur J Endocrinol, 2003;148:213–9
Elhassan YS, Alahdab F, Prete A, et al. Natural History of Adrenal Incidentalomas With and Without Mild Autonomous Cortisol Excess: A Systematic Review and Meta-analysis. Ann Intern Med 2019;171:107-16. 10.7326/M18-3630
Fernandez-Berge Daniel, Antonio Cabrera de Leo, Hector Sanz, Roberto Elosua, Maria J. Guembe, Maite Alzamora et al. Metabolic Syndrome in Spain: Prevalence and Coronary Risk Associated With Harmonized Definition and WHO Proposal. DARIOS Study. Rev Esp Cardiol. 2012;65(3):241-248
Giordano R, Marinazzo E, Berardelli R et al. Long-term morphological, hormonal, and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas. Eur J Endocrinol 2010; 162:779–85
Grumbach MM, Biller BM, Braunstein GD, Campbell KK, Carney JA, Godley PA, et al. Management of the clinically inapparent adrenal mass ("incidentaloma"). Ann Intern Med. 2003 Mar 4;138(5):424-9. doi: 10.7326/0003-4819-138-5-200303040-00013
Lee JW, Cho YK, Ryan M, Kim H, Lee SW, Chang E, Joo KJ, Kim JT, Kim BS, Sung KC. Serum uric Acid as a predictor for the development of nonalcoholic Fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study. Gut Liver. 2010 Sep;4(3):378-83
Lehto S, Niskanen L, Ronnemaa T et al. Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke. 1998, 29:635-9
Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012 Dec 15;380(9859):2224-60. doi: 10.1016/S0140-6736(12)61766-8
Lonardo A, Loria P, Leonardi F, Borsatti A, Neri P, Pulvirenti M, Verrone AM, Bagni A, Bertolotti M, Ganazzi D, Carulli N; POLI.ST.E.N.A. Study Group. Policentrica Steatosi Epatica Non Alcolica. Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study. Dig Liver Dis. 2002 Mar;34(3):204-11. doi: 10.1016/s1590-8658(02)80194-3
Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Alì A, Giovagnetti M, Opocher G, Angeli A. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab. 2000 Feb;85(2):637-44. doi: 10.1210/jcem.85.2.6372
Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck ML. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension. 2003 Oct;42(4):474-80
Morelli V, Reimondo G, Giordano R, et al. Long-term follow-up in adrenal incidentalomas: an Italian multicenter study. J Clin Endocrinol Metab 2014;99:827-34.10.1210/jc.2013-3527, 58
National Diabetes Information Clearinghouse, US Department of Health and Human Services Diabetes Fact Sheet. http://diabetes.niddk.nih.gov/dm/pubs/overview/. (Accessed 21 April 2018)
Peppa M, Boutati E, Koliaki C et al. Insulin resistance and metabolic syndrome in patients with non-functioning adrenal incidentalomas: a cause-effect relationship? Metabolism 2010; 59: 1435–41
Peppa M, Koliaki C, Nikolopoulos P, Raptis SA. Skeletal muscle insulin resistance in endocrine disease. J Biomed Biotechnol. 2010;2010:527850
Petta S, Cammà C, Cabibi D, Di Marco V, Craxì A. Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2011 Oct;34(7):757-66
Polednak AP. Estimating the number of U.S. incident cancers attributable to obesity and the impact on temporal trends in incidence rates for obesity-related cancers. Cancer Detect Prev. 2008;32(3):190-9. doi: 10.1016/j.cdp.2008.08.004
Prasad D. S., Z. Kabir, A. K. Dash, B. C. Das. Prevalence and risk factors for metabolic syndrome in Asian Indians: A community study from urban Eastern India. J Cardiovasc Dis Res. 2012 Jul-Sep; 3(3): 204–211
Rossi R, Tauchmanova L, Luciano A, et al. Subclinical Cushing‘s syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab 2000;85:1440-8
Ryu S, Chang Y, Kim SG, Cho J, Guallar E. Serum uric acid levels predict incident nonalcoholic fatty liver disease in healthy Korean men. Metabolism. 2011 Jun;60(6):860-6
Singh PK, Buch HN. Adrenal incidentaloma: evaluation and management. J Clin Pathol. 2008;61:1168–73
Sirota JC, McFann K, Targher G, Johnson RJ, Chonchol M, Jalal DI. Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey. Metabolism. 2013 Mar;62(3):392-9
Stevens GA, Singh GM, Lu Y, Danaei G, Lin JK, Finucane MM, et al. National, regional, and global trends in adult overweight and obesity prevalences. Popul Health Metr. 2012 Nov 20;10(1):22. doi: 10.1186/1478-7954-10-22
Tauchmanovà L, Rossi R, Biondi B, et al. Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab 2002;87:4872-8. 10.1210/jc.2001-011766
Terzolo M, Pia A, Alı` A et al. Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab 2002; 87: 998–1003
Vassilatou E, Vryonidou A, Michalopoulou S et al. Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study.Clin Endocrinol (Oxf). 2009;70:674–9
Xu C, Yu C, Xu L, Miao M, Li Y. High serum uric acid increases the risk for nonalcoholic Fatty liver disease: a prospective observational study. PLoS One. 2010 Jul 14;5(7):e11578
Yener S, Ertilav S, Secil M et al. Prospective evaluation of tumor size and hormonal status in adrenal incidentalomas. J Endocrinol Invest. 2010;33:32–6
Zhang W, Tang ZY, Wang WQ, Ning G. Metabolic syndrome in patients with adrenocortical adenoma. 2006;86:3397–400
Zheng X, Gong L, Luo R, Chen H, Peng B, Ren W, Wang Y. Serum uric acid and non-alcoholic fatty liver disease in non-obesity Chinese adults. Lipids Health Dis. 2017;16:202
